Ciliary Body and Choroid Melanoma, Medium/Large Size Completed Phase 2 Trials for Cixutumumab (DB12250)

IndicationStatusPhase
DBCOND0030825 (Ciliary Body and Choroid Melanoma, Medium/Large Size)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01413191Cixutumumab in Treating Patients With Metastatic Melanoma of the EyeTreatment